SCHEMBL30289571

SCHEMBL30289571

Cn1c(=O)[nH]c2ccc(-c3ccnc(C(=O)OC(C)(C)C)c3)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 12/20 0.47
▸ GABRG2 P18507 12/20 0.47
▸ GABRB3 P28472 12/20 0.47
▸ GABRA3 P34903 11/20 0.47
▸ GABRA2 P47869 11/20 0.47
▸ GABRA5 P31644 11/20 0.47
▸ GABRA6 Q16445 9/20 0.47
▸ PGR P06401 2/20 0.47
▸ GABRA4 P48169 5/20 0.43
▸ GABRP O00591 1/20 0.41
▸ GABRD O14764 1/20 0.41
▸ GABRB1 P18505 1/20 0.41
▸ GABRB2 P47870 1/20 0.41
▸ GABRE P78334 1/20 0.41
▸ GABRG1 Q8N1C3 1/20 0.41
▸ GABRG3 Q99928 1/20 0.41
▸ GABRQ Q9UN88 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ MAOB P27338 3/20 0.38
▸ CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289054 0.78 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL30939011 0.71 MAOB (0.54) PGRLMNAMAOB
SCHEMBL24607774 0.70 PGR (0.42) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL29751413 0.70 PGR (0.42) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL12207033 0.70 PSMB8 (0.49) PGRLMNAMAOB
SCHEMBL29996454 0.69 PGR (0.61) GABRG2GABRB3GABRA3GABRA5PGR
SCHEMBL30288955 0.69 NAMPT (0.49) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL12056344 0.67 LMNA (0.53) PGRLMNAMAOBCDK2AKT1
SCHEMBL13105640 0.67 GABRG2 (0.46) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL163615 0.67 GABRG2 (0.46) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback